These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 17610384

  • 1. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.
    Bandelow B, Wedekind D, Leon T.
    Expert Rev Neurother; 2007 Jul; 7(7):769-81. PubMed ID: 17610384
    [Abstract] [Full Text] [Related]

  • 2. Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety.
    Owen RT.
    Drugs Today (Barc); 2007 Sep; 43(9):601-10. PubMed ID: 17940637
    [Abstract] [Full Text] [Related]

  • 3. Pregabalin for the treatment of generalized anxiety disorder.
    Wensel TM, Powe KW, Cates ME.
    Ann Pharmacother; 2012 Mar; 46(3):424-9. PubMed ID: 22395254
    [Abstract] [Full Text] [Related]

  • 4. Long-term efficacy of pregabalin in generalized anxiety disorder.
    Feltner D, Wittchen HU, Kavoussi R, Brock J, Baldinetti F, Pande AC.
    Int Clin Psychopharmacol; 2008 Jan; 23(1):18-28. PubMed ID: 18090504
    [Abstract] [Full Text] [Related]

  • 5. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K, Pollack MH, Feltner DE, Lydiard RB, Zimbroff DL, Bielski RJ, Tobias K, Brock JD, Zornberg GL, Pande AC.
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model.
    Nutt D, Mandel F, Baldinetti F.
    J Psychopharmacol; 2009 Nov; 23(8):867-73. PubMed ID: 18635690
    [Abstract] [Full Text] [Related]

  • 14. Pregabalin: From molecule to medicine.
    Kavoussi R.
    Eur Neuropsychopharmacol; 2006 Jul; 16 Suppl 2():S128-33. PubMed ID: 16765030
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder.
    Lydiard RB, Rickels K, Herman B, Feltner DE.
    Int J Neuropsychopharmacol; 2010 Mar; 13(2):229-41. PubMed ID: 19737439
    [Abstract] [Full Text] [Related]

  • 19. Pregabalin: in the treatment of generalised anxiety disorder.
    Frampton JE, Foster RH.
    CNS Drugs; 2006 Mar; 20(8):685-93; discussion 694-5. PubMed ID: 16863276
    [Abstract] [Full Text] [Related]

  • 20. How well do randomized controlled trial data generalize to 'real-world' clinical practice settings? A comparison of two generalized anxiety disorder studies.
    Kasper S, Brasser M, Schweizer E, Lyndon G, Prieto R.
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):125-32. PubMed ID: 24290532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.